Navigation Links
Joint Commission Recognizes Spectrum Healthcare Resources
Date:9/1/2009

KNOXVILLE, Tenn., Sept. 1 /PRNewswire/ -- Spectrum Healthcare Resources (Spectrum) recently passed The Joint Commission's intra-cycle certification, a program that offers an independent, comprehensive evaluation of a staffing firm's ability to provide competent staffing services. This certification follows Spectrum's third consecutive Gold Seal of Approval, which the organization received in 2008.

"Healthcare organizations that contract with Spectrum can look to the intra-cycle certification as an assurance that Spectrum demonstrates a commitment to providing and continuously improving quality services," says Michele Sacco, M.S., executive director, Health Care Staffing Services Certification, Joint Commission.

As part of Spectrum's third Gold Seal of Approval, the organization underwent an unannounced, on-site review of its compliance with national standards addressing how staffing firms determine the qualifications and competency of their staff, how they place their staff, and how they monitor staff's performance.

"These awards recognize Spectrum's dedication to providing qualified healthcare professionals who provide safe, high-quality care to patients," says George Tracy, President, Spectrum. "We're proud to receive the Joint Commission's certification and Gold Seal of Approval."

About Spectrum Healthcare Resources

Spectrum is the leader of organizations that provide physicians, clinical personnel, and management services to military treatment facilities (MTFs) throughout the United States. Spectrum serves 126 MTFs and six Veterans Affairs (VA) facilities nationwide through various contracting vehicles, including TriCare. Spectrum provides these medical facilities with more than 400 physicians, 1,000 nurses, 250 mid-level providers, and 900 allied health professionals. A division of TeamHealth, Spectrum was established in 1988 to ensure that systems and processes are designed to meet the unique needs of the military health and VA systems.

About The Joint Commission

Founded in 1951, The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of health care accreditation and related services that support performance improvement in health care organizations. The Joint Commission evaluates and accredits more than 15,000 health care organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,800 other health care organizations that provide long term care, assisted living, behavioral health care, laboratory and ambulatory care services. The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, the Joint Commission provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, the Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about the Joint Commission at www.jointcommission.org.


'/>"/>
SOURCE Spectrum Healthcare Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
4. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
5. The impact of physical activity on weight-bearing knee joint
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken
8. The Joint Commission Enhances Quality Check Website
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
11. Delaware Court Approves Bioenvision, Genzyme Joint Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: